Mucosal immunology research design should address not just cytokines and cells, but also clinical data and controls
- 28 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 96 (3) , 377-378
- https://doi.org/10.1111/j.1365-2249.1994.tb06037.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's diseaseClinical and Experimental Immunology, 1994
- Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.Gut, 1994
- Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin 8Gastroenterology, 1993
- Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.Gut, 1993
- Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cellsGastroenterology, 1993
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte labelGastroenterology, 1988
- Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel diseaseGastroenterology, 1986